Atlas Trials

Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus Erythematosus

Clinical trial NCT00278538 · COMPLETED

Trial details

NCT number
NCT00278538
Sponsor
Northwestern University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Systemic Lupus Erythematosus
Start date
2005-09-23
Primary completion
2018-12-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.